Bio-experienced psoriasis patients treated with anti-interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patients.

Autor: Margiotta, Flavia Manzo, Michelucci, Alessandra, Panduri, Salvatore, Angeloni, Laura, Fidanzi, Cristian, Granieri, Giammarco, Morganti, Riccardo, Romanelli, Marco, Dini, Valentina
Zdroj: JEADV Clinical Practice; Mar2024, Vol. 3 Issue 1, p65-75, 11p
Databáze: Complementary Index